A.R.T. Advisors’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-48,077
Closed -$54K 1881
2017
Q3
$54K Sell
48,077
-34,320
-42% -$36.8K ﹤0.01% 1253
2017
Q2
$95K Buy
+82,397
New +$95.8K 0.01% 1260

A.R.T. Advisors's OCRX Position: Q4 2017 in Review

A.R.T. Advisors sold out of Ocera Therapeutics, Inc. (OCRX) in Q4 2017, closing a stake of 48,077 shares — an estimated $54K sold.

A.R.T. Advisors first reported a position in OCRX in Q2 2017 and held it in 2 quarters. The position peaked at $95K in Q2 2017. 0 funds tracked by Wall St. Rank hold OCRX as of Q4 2017.

  • A.R.T. Advisors reported no remaining Ocera Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
  • A.R.T. Advisors sold 48,077 Ocera Therapeutics, Inc. shares in Q4 2017, an estimated $54K.
  • A.R.T. Advisors first reported a position in Ocera Therapeutics, Inc. in Q2 2017 and held it in 2 quarters.
  • A.R.T. Advisors's Ocera Therapeutics, Inc. position peaked at $95K in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q4 2017.

Based on A.R.T. Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.